GENOMIC CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES

被引：0

作者：

Bernard, E. ^{[1
]}

Hasserjian, R. ^{[2
]}

Greenberg, P. ^{[3
]}

Ossa, J. Arango ^{[1
]}

Creignou, M. ^{[4
]}

Nannya, Y. ^{[5
]}

Tuechler, H. ^{[6
]}

Medina-Martinez, J. ^{[1
]}

Levine, M. ^{[1
]}

Jadersten, M. ^{[4
]}

Germing, U. ^{[7
]}

Sanz, G. ^{[8
]}

Van De Loosdrecht, A. ^{[9
]}

Kosmider, O. ^{[10
]}

Follo, M. ^{[11
]}

Thol, F. ^{[12
]}

Zamora, L. ^{[13
]}

Pinheiro, R. ^{[14
]}

Pellagatti, A. ^{[15
]}

Elias, H. ^{[1
]}

Haase, D. ^{[16
]}

Ganster, C. ^{[16
]}

Ades, L. ^{[17
]}

Tobiasson, M. ^{[4
]}

Palomo, L. ^{[18
]}

Della Porta, M. ^{[19
]}

Fenaux, P. ^{[20
]}

Belickova, M. ^{[21
]}

Savona, M. ^{[22
]}

Klimek, V. ^{[23
]}

Santos, F. ^{[24
]}

Boultwood, J. ^{[15
]}

Kotsianidis, I. ^{[25
]}

Santini, V. ^{[26
]}

Sole, F. ^{[27
]}

Platzbecker, U. ^{[28
]}

Heuser, M. ^{[12
]}

Valent, P. ^{[29
]}

Finelli, C. ^{[30
]}

Voso, M. T. ^{[31
]}

Shih, L. -Y. ^{[32
]}

Fontenay, M. ^{[33
]}

Jansen, J. ^{[9
]}

Cervera-Zamora, J. ^{[34
]}

Gattermann, N. ^{[35
]}

Ebert, B. ^{[36
]}

Bejar, R. ^{[37
]}

Malcovati, L. ^{[38
,39
]}

Cazzola, M. ^{[40
]}

Ogawa, S. ^{[41
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Computat Oncol Serv, 1275 York Ave, New York, NY 10021 USA

[2] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

[3] Stanford Univ, Ctr Canc, Med Hematol, Stanford, CA 94305 USA

[4] Karolinska Inst, Dept Med Huddinge, Ctr Hematol & Regenerat Med, Stockholm, Sweden

[5] Univ Tokyo, Div Hematopoiet Dis Control, Tokyo, Japan

[6] Hanusch Hosp, Med Dept 3, Vienna, Austria

[7] Heinrich Heine Univ Duesseldorf, Hematol Oncol & Clin Immunol, Dusseldorf, Germany

[8] Hosp Univ La Fe, Inst Invest Sanitaria La Fe, Valencia, Spain

[9] Vrije Univ Amsterdam Med Ctr, Amsterdam Univ Med Ctr, Hematol, Amsterdam, Netherlands

[10] Inst Cochin, Paris, France

[11] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy

[12] Hannover Med Sch, Hematol Hemostasis Oncol & Stem Cell Transplantat, Hannover, Germany

[13] Hosp Badalona Germans Trias & Pujol, ICO Badalona, Josep Carreras Leukemia Res Inst, Hematol Serv, Badalona, Spain

[14] Ctr Res & Drug Dev, Canc Citogen Lab, Fortaleza, Ceara, Brazil

[15] Univ Oxford, Dept Med, Oxford, England

[16] Univ Med Gottingen, Clin Hematol & Med Oncol, Gottingen, Germany

[17] Hop St Louis, Hematol, Paris, France

[18] Hosp Univ Vall dHebron, Vall Dhebron Inst Oncol Vhio, Barcelona, Spain

[19] Humanitas Clin & Res Ctr, Unit Genom Hematol Malignances, Rozzano, MI, Italy

[20] Hop St Louis, Hematol, Paris, France

[21] Inst Hematol & Blood Transfus, Gen, Prague, Czech Republic

[22] Vanderbilt Univ, Sch Med, Div Hematol Oncol, Nashville, TN 37212 USA

[23] Syros Pharmaceut Inc, Clin Dev, Cambridge, MA USA

[24] Hosp Israelita Albert Einstein, Oncol Hematol Ctr, Sao Paulo, Brazil

[25] Gen Univ Hosp Alexandroupolis, Hematol, Alexandroupolis, Greece

[26] AOUC Univ Florence, MDS Unit, Hematol, Florence, Italy

[27] Univ Autonoma Barcelona, Myelodysplast Syndromes Res Grp, Hosp Germans Trias & Pujol, Josep Carreras Leukaemia Res Inst,ICO, Badalona, Spain

[28] Univ Leipzig, Hematol Cellular Therapy Infect Dis & Hemostasis, Leipzig, Germany

[29] Med Univ Vienna, Dept Int Med 1, Div Hematol, Hemostaseol, Vienna, Austria

[30] Osped Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy

[31] Tor Vergata Univ, Dept Biomed & Prevent, Rome, Italy

[32] Chang Gung Univ, Div Hematol Oncol, Taoyuan, Taiwan

[33] Univ Paris Cite, Cochin Hosp, Hematol, Paris, France

[34] Inst Invest Sanitaria La Fe, Dept Hematol, Valencia, Spain

[35] Heinrich Heine Univ Duesseldorf, Hematol Oncol & Clin Immunol, Dusseldorf, Germany

[36] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[37] Univ Calif San Diego, Ctr Canc, La Jolla, CA USA

[38] Univ Pavia, Pavia, Italy

[39] IRCCS S Matteo Hosp Fdn, Dept Mol Med & Hematol Oncol, Pavia, Italy

[40] IRCCS Policlin San Matteo Fdn, Dept Hematol & Oncol, Pavia, Italy

[41] Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan

[42] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, Stockholm, Sweden

来源：

LEUKEMIA RESEARCH | 2023年 / 128卷

关键词：

D O I：

10.1016/j.leukres.2023.107146

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P011

引用

页数：1

共 50 条

[21] CLASSIFICATION AND MORPHOLOGICAL FEATURES OF THE MYELODYSPLASTIC SYNDROMES
GOASGUEN, JE
BENNETT, JM
SEMINARS IN ONCOLOGY, 1992, 19 (01) : 4 - 13
[22] DIAGNOSIS, CLASSIFICATION, AND COURSE OF MYELODYSPLASTIC SYNDROMES
MCKENNA, RW
ALLISON, PM
CLINICS IN LABORATORY MEDICINE, 1990, 10 (04) : 683 - 706
[23] Classification and Prognostic Evaluation of Myelodysplastic Syndromes
Cazzola, Mario
Della Porta, Matteo G.
Travaglino, Erica
Malcovati, Luca
SEMINARS IN ONCOLOGY, 2011, 38 (05) : 627 - 634
[24] Diagnosis, classification, and cytogenetics of myelodysplastic syndromes
Vallespí, T
Imbert, M
Mecucci, C
Preudhomme, C
Fenaux, P
HAEMATOLOGICA, 1998, 83 (03) : 258 - 275
[25] The myelodysplastic syndromes: towards a functional classification
Mijovic, A
Mufti, GJ
BLOOD REVIEWS, 1998, 12 (02) : 73 - 83
[26] Prognostic classification in myelodysplastic syndromes.
Sanz, GF
Morel, P
PATHOLOGIE BIOLOGIE, 1997, 45 (08): : 617 - 626
[27] Myelodysplastic Syndromes Classification and Risk Stratification
Komrokji, Rami S.
Zhang, Ling
Bennett, John M.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (02) : 443 - +
[28] Myelodysplastic syndromes: molecular pathogenesis and genomic changes
Florian Nolte
Wolf-K. Hofmann
Annals of Hematology, 2008, 87 : 777 - 795
[29] Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration
Chen-Liang, Tzu-Hua
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (10)
[30] GENOMIC AND TRANSCRIPTOMIC CHARACTERIZATION OF MYELODYSPLASTIC SYNDROMES/MYELOPROLIFERATIVE NEOPLASMS
Acha, P.
Ezponda, T.
Vilas-Zornoza, A.
Xicoy, B.
Palomo, L.
Fuster-Tormo, F.
Manzanares, A.
Zufiaurre, N. Berastegui
Zamora, L.
Jerez, A.
Lopez-Cadenas, F.
Diez-Campelo, M.
Bonadies, N.
Cervera-Zamora, J.
Mascaro, M.
Montoro, M. J.
Hernandez, F.
Raya, J. M.
Ancin, I.
Vahi, M.
Garrastazul, M. P.
Hermosin-Ramos, M. L.
Mallo, M.
Grau, J.
Marce, S.
Cabezon, M.
Prosper, F.
Sole, F.
LEUKEMIA RESEARCH, 2023, 128

← 1 2 3 4 5 →